Position in TGTX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$331,453
-$181,255 QoQ
Shares Held
6,033
-53.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#275
of 423 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Dec 31, 2021CallValue
$19,000
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $6,495,341 across 14 Biotechnology names. TGTX ranks #7 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,787 | $1,881,116 | |
| 2 | ARGX |
Argenx SE
|
1,077 | $999,208 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,289 | $803,743 | |
| 4 | RLAY |
Relay Therapeutics, Inc.
|
35,687 | $667,703 | |
| 5 | MRNA |
Moderna, Inc.
|
7,412 | $519,062 | |
| 6 | VCEL |
Vericel Corp
|
9,289 | $413,267 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
This page
|
6,033 | $331,453 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,838 | $241,563 |
All Filings in TGTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $331,453 | 6,033 | Shares | Sole | 2026-07-08 | |
| 2025-03-31 | $512,708 | 13,003 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $407,313 | 13,532 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $239,115 | 10,223 | Shares | Sole | 2024-10-10 | |
| 2024-03-31 | $659,262 | 43,344 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $1,081,164 | 63,300 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $516,648 | 61,800 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $1,497,852 | 60,300 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $982,112 | 65,300 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $813,904 | 68,800 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $194,768 | 32,900 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $178,500 | 42,000 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $162,621 | 17,100 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $19,000 | 1,000 | Call | Sole | 2022-01-07 | |
| 2021-12-31 | $429,400 | 22,600 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $49,920 | 1,500 | Call | Sole | 2021-11-02 | |
| 2021-09-30 | $539,136 | 16,200 | Shares | Sole | 2021-11-02 | |
| 2021-03-31 | $48,200 | 1,000 | Shares | Sole | 2021-04-12 | |
| 2021-03-31 | $72,300 | 1,500 | Call | Sole | 2021-04-12 | |
| 2020-12-31 | $78,030 | 1,500 | Call | Sole | 2021-02-11 | |
| 2020-12-31 | $26,010 | 500 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $13,380 | 500 | Shares | Sole | 2020-10-28 | |
| 2020-09-30 | $13,380 | 500 | Call | Sole | 2020-10-28 | |
| No filing history on record for this holder in this stock. | ||||||